Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension
医学
内科学
作者
Luke J. Laffin,Branko Kopjar,Carrie Melgaard,Kathy Wolski,Jessica Ibbitson,Shivani Bhikam,Matthew R. Weir,Elizabeth Ofili,Reena Mehra,James M. Luther,Debbie L. Cohen,Ashish Sarraju,M. J. Wilkinson,John M. Flack,David Rodman,Steven E. Nissen
Lorundrostat was associated with greater reductions in 24-hour average blood pressure than placebo in participants with uncontrolled and treatment-resistant hypertension. (Funded by Mineralys Therapeutics; Advance-HTN ClinicalTrials.gov number, NCT05769608.).
PDF的下载单位、IP信息已删除
浮游
无极微光
pluto
GingerF
Zx_1993
小青椒
嘿嘿
yznfly
昏睡的蟠桃
avalanche
xxfsx
Frank
风吹麦田
iNk
wxyshare
ccm
ccc2
dew
liao
kentonchow
hackfeng
Tourist
你嵙这个期刊没买
殷勤的紫槐
皖公网安备34019202002308
